Chancery Orders Keryx To Turn Over Akebia Merger Records
The Delaware Chancery Court ruled Thursday that a Keryx Biopharmaceuticals Inc. investor has offered a credible basis for his demand of records related to the company's merger with Akebia Therapeutics Inc....To view the full article, register now.
Already a subscriber? Click here to view full article